This course was last updated on
January 31, 2019
CME credit has expired.
Welcome to this subway-themed activity where you can choose different subway lines for the education that is the most relevant to you. Michelle Petri, MD, MPH, and Daniel J. Wallace, MD, FACP, MACR, provide their experience and insight into the diagnosis and management of systemic lupus erythematosus (SLE), with perspectives for both general practitioners and rheumatologists.

Content Areas

  • Signs and symptoms
  • Diagnosis
  • Organ-threatening disease
  • Non-organ-threatening disease
  • Treatment goals
  • Adherence and monitoring
  • Prognosis
  • Research topics
  • Clinical trials

Target Audience

This activity was developed for rheumatologists, family physicians, internal medicine physicians, nurse practitioners, nurses, physician assistants and other healthcare professionals who have an interest in systemic lupus erythematosus (SLE).


Daniel J. Wallace, MD, FACP, MACR
Daniel J. Wallace, MD, FACP, MACR
Associate Director, Rheumatology Fellowship Program
Board of Governors, Cedars-Sinai Medical Center
Professor of Medicine, Cedars-Sinai Medical Center
David Geffen School of Medicine Center at UCLA
In affiliation with Attune Health
Los Angeles, California
Michelle Petri, MD, MPH
Michelle Petri, MD, MPH
Professor of Medicine
Johns Hopkins University School of Medicine
Baltimore, Maryland
Enter your information to begin.
CME Credit
Available Credit: 2.00 AMA PRA Category 1 Credits™.
2.00 AANP Contact Hours
2.00 ANCC Contact Hours
Opens: January 31, 2019
Expires: January 30, 2020
Target Audience: Rheumatologists
Family Physicians
Internal Medicine Physicians
Nurse Practitioners
Physician Assistants
Other Healthcare Providers
This educational activity is supported by an educational grant from GlaxoSmithKline.